Yu et al. demonstrated the anti-tumor effect of β-lapachone on breast cancer tumors with a variation in the phosphorylation of AKT, 4EBP-1 and S6, which are related to the mTOR pathway and is also related to the apoptotic activity of this compound in gastric carcinoma cells [101]. This evidence concerns the gene AKT1 and breast cancer.